XML 58 R44.htm IDEA: XBRL DOCUMENT v3.26.1
Schedule of Cash, Cash Equivalents and Marketable Investment Securities (Details) - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash and Cash Equivalents [Line Items]    
Adjusted Cost $ 11,884,607 $ 29,329,199
Total Unrealized Gains / (Losses) 418,443
Fair Value 11,884,607 29,747,642
Cash and Cash Equivalents 11,884,607 2,936,544
Marketable Securities 26,811,098
Fair Value, Inputs, Level 2 [Member]    
Cash and Cash Equivalents [Line Items]    
Adjusted Cost   26,392,655
Total Unrealized Gains / (Losses)   418,443
Fair Value   26,811,098
Cash and Cash Equivalents  
Marketable Securities   26,811,098
Cash [Member]    
Cash and Cash Equivalents [Line Items]    
Adjusted Cost 11,884,607 2,936,544
Total Unrealized Gains / (Losses)
Fair Value 11,884,607 2,936,544
Cash and Cash Equivalents 11,884,607 2,936,544
Marketable Securities
US Treasury Securities [Member] | Fair Value, Inputs, Level 2 [Member]    
Cash and Cash Equivalents [Line Items]    
Adjusted Cost   26,392,655
Total Unrealized Gains / (Losses)   418,443
Fair Value   26,811,098
Cash and Cash Equivalents  
Marketable Securities   $ 26,811,098